Get the Stockscreener App
1.725
0.88%
0.015
Beyondspring Inc stock is traded at $1.725, with a volume of 2,351.
It is up +0.88% in the last 24 hours and up +25.91% over the past month.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.
See More
Previous Close:
$1.71
Open:
$1.73
24h Volume:
2,351
Relative Volume:
0.07
Market Cap:
$70.93M
Revenue:
$1.88M
Net Income/Loss:
$-16.06M
P/E Ratio:
-8.7209
EPS:
-0.1978
Net Cash Flow:
$-50.09M
1W Performance:
+7.14%
1M Performance:
+25.91%
6M Performance:
-0.29%
1Y Performance:
+9.87%
1-Day Range:
$1.66
$1.73
1-Week Range:
$1.52
$1.75
52-Week Range:
$0.98
$3.44
Beyondspring Inc Stock (BYSI) Company Profile
Name
Beyondspring Inc
Sector
Industry
Phone
646-528-4184
Address
100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR, FLORHAM PARK, NY
Compare BYSI vs VRTX, REGN, ARGX, ALNY, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BYSI
Beyondspring Inc
|
1.725 | 70.93M | 1.88M | -16.06M | -50.09M | -0.1978 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Beyondspring Inc Stock (BYSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-21 | Downgrade | BofA Securities | Buy → Underperform |
| Dec-02-21 | Downgrade | Jefferies | Buy → Hold |
| Dec-01-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Dec-01-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-09-21 | Initiated | Robert W. Baird | Outperform |
| Aug-04-21 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Apr-05-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-11-21 | Initiated | BofA Securities | Buy |
| Dec-29-20 | Initiated | Evercore ISI | Outperform |
| Feb-07-20 | Initiated | Jefferies | Buy |
| Jan-10-20 | Initiated | Nomura | Buy |
| Dec-03-19 | Initiated | William Blair | Outperform |
| Jul-10-19 | Reiterated | H.C. Wainwright | Buy |
| Apr-30-19 | Downgrade | Maxim Group | Buy → Hold |
| Oct-25-18 | Reiterated | Maxim Group | Buy |
View All
Beyondspring Inc Stock (BYSI) Latest News
BeyondSpring Stock Crosses 50-Day Moving Average - National Today
BeyondSpring (NASDAQ:BYSI) Stock Crosses Above 50 Day Moving AverageShould You Sell? - MarketBeat
BeyondSpring (BYSI) director receives 22,165 stock options grant - Stock Titan
Director Delaney granted BYSI stock options under 2017 plan - Stock Titan
BeyondSpring (BYSI) director receives 21,730 options at $1.64 strike - Stock Titan
BeyondSpring (BYSI) awards CSO 17,840 stock options at $1.64 strike - Stock Titan
BeyondSpring (BYSI) CEO Huang Lan receives grant of 11,514 stock options - Stock Titan
BeyondSpring (BYSI) director Xu Sihai awarded 18,689 stock options at $1.64 - Stock Titan
BeyondSpring Inc. (BYSI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026 - Bitget
BeyondSpring lands April AACR slot for plinabulin-ADC cancer data - Stock Titan
BeyondSpring (NASDAQ:BYSI) Trading Down 0.6%Should You Sell? - MarketBeat
Layoff Watch: Can BeyondSpring Inc beat the S P 5002026 Price Swings & AI Powered Market Entry Strategies - baoquankhu1.vn
Overcoming PD-1/L1 Resistance: Translational Insights with Plinabulin - marketscreener.com
BeyondSpring : Corporate Presentation - marketscreener.com
BeyondSpring Inc. 2025 Annual Report – Plinabulin Clinical Progress, SEED TPD Platform, and Strategic Collaborations with Eli Lilly & Eisai - Minichart
EV Market: How does BeyondSpring Inc perform in inflationary periodsWeekly Trade Summary & Growth Focused Stock Pick Reports - baoquankhu1.vn
BeyondSpring Inc. (BYSI) Reports FY2025 Earnings - AlphaStreet
BeyondSpring Files 2025 Annual Report on Form 10-K - Bitget
BeyondSpring 10-K: $0M Revenue, $(0.02) EPS, net loss $(14.22)M - tradingview.com
BeyondSpring (NASDAQ: BYSI) posts 2025 loss and warns it needs more funding - Stock Titan
BYSI: Net loss narrowed to $14.2M in 2025 as Plinabulin advanced in global NSCLC trials - TradingView
BeyondSpring Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
BeyondSpring Inc. Confirms Phase 3 Overall Survival Benefit for Plinabulin in NSCLC and Plans DUBLIN-4 Study - Quiver Quantitative
Jobs Data: How does BeyondSpring Inc compare to its peersTrade Analysis Summary & Daily Entry Point Trade Alerts - baoquankhu1.vn
BeyondSpring (NASDAQ: BYSI) narrows 2025 loss as Plinabulin Phase 3 data drive new trial - Stock Titan
Lung cancer drug shows survival gain as BeyondSpring readies new trial - Stock Titan
Wall Street Recap: Whats the RSI of BeyondSpring Inc stockPortfolio Return Summary & Reliable Price Action Trade Plans - baoquankhu1.vn
BeyondSpring (BYSI) Stock Analysis Report | Financials & Insights - Benzinga España
Buyback Watch: Will BeyondSpring Inc stock go up in YEAR2026 Breakouts & Fast Momentum Entry Tips - baoquankhu1.vn
Stock List: Research Stocks from Around the World - GuruFocus
Aug Mood: How does BeyondSpring Inc compare to its peersWatch List & Technical Entry and Exit Tips - baoquankhu1.vn
Institution Moves: How does BeyondSpring Inc compare to its peersPortfolio Gains Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Is BeyondSpring Inc stock influenced by commodity pricesJuly 2025 Summary & Community Verified Trade Signals - baoquankhu1.vn
BeyondSpring Stock Drops Below 50-Day Average - National Today
BeyondSpring (NASDAQ:BYSI) Stock Passes Below 50-Day Moving AverageShould You Sell? - MarketBeat
Travel Stocks: Whats the beta of BeyondSpring Inc stock2025 Top Gainers & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
XGN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
BYSI Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
OPTX PE Ratio & Valuation, Is OPTX Overvalued - Intellectia AI
US Market Wrap: How does BeyondSpring Inc compare to its peersWeekly Earnings Recap & Technical Confirmation Trade Alerts - baoquankhu1.vn
BeyondSpring Shares Rise 2.4% - National Today
Will BeyondSpring Inc. benefit from rising consumer demand2025 Key Highlights & Weekly Chart Analysis and Trade Guides - mfd.ru
Will BeyondSpring Inc. outperform tech stocksOptions Play & Community Consensus Trade Signals - mfd.ru
Risk Recap: How does BeyondSpring Inc perform in inflationary periodsQuarterly Portfolio Report & Precise Buy Zone Identification - baoquankhu1.vn
Will BeyondSpring Inc. outperform during market ralliesJuly 2025 Reactions & Free Risk Controlled Daily Trade Plans - mfd.ru
Forecast Cut: What dividend growth rate does BeyondSpring Inc offerWeekly Investment Summary & Technical Buy Zone Confirmation - baoquankhu1.vn
BeyondSpring (NASDAQ:BYSI) Shares Up 2.4%Here's Why - MarketBeat
Is BeyondSpring Inc stock forming a cup and handle2025 Historical Comparison & Fast Moving Trade Plans - baoquankhu1.vn
Is BeyondSpring Inc.’s growth already priced inRecession Risk & Short-Term High Return Strategies - mfd.ru
Beyondspring Inc Stock (BYSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Beyondspring Inc Stock (BYSI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Decheng Capital China Life Sci | 10% Owner |
Oct 17 '25 |
Sale |
1.76 |
45,513 |
80,103 |
1,518,893 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 13 '25 |
Sale |
1.70 |
107,361 |
182,514 |
1,696,659 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 14 '25 |
Sale |
1.65 |
28,495 |
47,017 |
1,668,164 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 15 '25 |
Sale |
1.65 |
17,960 |
29,634 |
1,650,204 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 08 '25 |
Sale |
1.77 |
7,507 |
13,287 |
1,810,389 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 09 '25 |
Sale |
1.81 |
3,979 |
7,202 |
1,806,410 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 10 '25 |
Sale |
1.77 |
2,390 |
4,230 |
1,804,020 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 06 '25 |
Sale |
1.78 |
17,500 |
31,150 |
1,819,996 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 07 '25 |
Sale |
1.79 |
2,100 |
3,759 |
1,817,896 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 03 '25 |
Sale |
1.76 |
600 |
1,056 |
1,837,496 |
0.49%
1.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):